Hy2Care

Year of investment: 2019

Hy2Care is developing a two-component injectable and bioresorbable hydrogel for the treatment of cartilage defects. The first application is aimed at the functional repair of cartilage defects in the knee via an arthroscopic procedure. The injectable hydrogels are composed of natural polymer conjugates that are biocompatible, functional and integrate well with cartilage and bone.